Financials
Interim results for the six months ended 30 June | Sep. 10, 2024 |
Half-Year Trading Update | Jul. 16, 2024 |
Final results for the year ended 31 December 2023 | Mar. 19, 2024 |
Interim results | Sep. 05, 2023 |
Half-Year Trading Update | Jul. 17, 2023 |
Final results for the year ended 31 December 2022 | Mar. 21, 2023 |
Half-year Report | Sep. 07, 2022 |
Proxies
Result of AGM | Apr. 25, 2024 |
Result of AGM | Apr. 26, 2022 |
Result of AGM | Jun. 03, 2021 |
Result of AGM | Jun. 30, 2020 |
Result of AGM | Jun. 27, 2019 |
Notice of AGM | Jun. 04, 2019 |
Posting of Annual Report and Notice of AGM | Apr. 27, 2018 |
Ownership Update
Grant of share options | Jul. 18, 2024 |
Holding(s) in Company | Jul. 03, 2024 |
Holding(s) in Company | Jun. 24, 2024 |
Exercise of Options, Director Dealing and TVR | Jun. 18, 2024 |
Holding(s) in Company | Apr. 05, 2024 |
Holding(s) in Company | Jan. 29, 2024 |
2023 LTIP Grant | Jan. 23, 2024 |
Announcements
Form 8.3 - Tissue Regenix Group PLC | Nov. 05, 2024 |
Response to media speculation | Nov. 04, 2024 |
Confirmation of results | Aug. 21, 2024 |
Building purchase | Jun. 14, 2024 |
HPRA approval & distribution agreement in Spain | Oct. 30, 2023 |
New sports medicine product launch | Sep. 05, 2023 |
Exercise of Options and Total Voting Rights | Aug. 31, 2023 |